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Descriptive studies have delineated a developmental change in neurotransmitter phenotype from noradrenergic to
cholinergic in the sympathetic innervation of sweat glands in rodent footpads. Transplantation and culture experiments
provide evidence that interactions with the target tissue induce this change. Recent studies with an antiserum that
recognizes the vesicular acetylcholine transporter (VAChT) suggest, however, that the development of cholinergic function
in sympathetic neurons, including those that innervate sweat glands, occurs prior to and does not require target contact. To
clarify these apparently contradictory findings, we directly compared the appearance of VAChT immunoreactivity in the
sympathetic neurons that innervate sweat glands with the time that axons contact this target. We find that VAChT
immunoreactivity is not detectable in either the axons or cell bodies of sweat gland neurons until several days after target
innervation. Before and during VAChT acquisition, the developing sweat gland innervation contains vesicular stores of
catecholamines. An analysis of mutant mice that lack sweat glands was undertaken to determine whether VAChT
expression requires target interactions and revealed that VAChT does not appear in the absence of glands. These findings,
together with previous studies, confirm the target dependence of cholinergic function in the sympathetic neurons that
innervate sweat glands. © 1998 Academic Press
INTRODUCTION
Many sympathetic neurons utilize a small molecule
transmitter, either norepinephrine or acetylcholine, and
one or more neuropeptides to influence target tissue func-
tion (Elfvin et al., 1993). While there are species differences,
correlations exist between particular target tissues and the
characteristic repertoire of transmitter and neuropeptides
in the sympathetic neurons that innervate them. Such
correlations, which have been widely observed in the pe-
ripheral nervous system, are referred to as chemical coding
(Furness et al., 1989). For example, sympathetic neurons
that innervate blood vessels, the pineal gland, and the iris
contain catecholamines and neuropeptide Y (Lundberg et
al., 1982; Lundberg et al., 1982; Schon et al., 1985) while
sympathetic neurons that innervate sweat glands contain
acetylcholine, vasoactive intestinal peptide, and calcitonin
gene-related peptide (Lundberg et al., 1980; Landis and
Fredieu, 1986; Lindh et al., 1989).
Examination of the developing rodent sweat gland inner-
vation has provided evidence that chemical coding can be
achieved via retrograde instructive signals from target tis-
sues which regulate the expression of neurotransmitter
synthetic enzymes and neuropeptides. Similarly, it is clear
that interactions with specific target tissues determine the
neuropeptide phenotype of ciliary ganglion neurons in the
developing chick embryo (Coulombe and Nishi, 1991; Cou-
lombe et al., 1993; Darland et al., 1995; Coulombe and Kos,
1997). For sweat glands, the initial gland innervation con-
tains tyrosine hydroxylase immunoreactivity (TH-IR) and
catecholamine histofluorescence (Landis and Keefe, 1983;
Landis et al., 1988; Guidry and Landis, 1995). In the adult
rat, however, the gland innervation lacks detectable cat-
echolamines and contains immunoreactivity for choline
acetyltransferase (ChAT), vasoactive intestinal peptide, and
calcitonin gene-related peptide (Landis and Keefe, 1983;
Leblanc and Landis, 1986; Landis et al., 1988). The results of
transplantation studies are consistent with the notion that
the target sweat glands play an instructive role in suppress-
ing noradrenergic and inducing cholinergic and peptidergic
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properties. When footpad skin containing sweat gland pri-
mordia is transplanted in place of thoracic hairy skin, the
noradrenergic sympathetic axons innervating the trans-
planted sweat glands lose their catecholaminergic proper-
ties and adopt a cholinergic phenotype (Schotzinger and
Landis, 1988; Schotzinger et al., 1994). Conversely, when
sweat gland primordia in footpads are replaced with parotid
gland, which normally receives noradrenergic sympathetic
innervation, the sympathetic fibers innervating the trans-
planted parotid maintain their catecholaminergic proper-
ties and fail to acquire cholinergic markers (Schotzinger and
Landis, 1990). Other experimental paradigms, including
transplantation of sweat glands to the anterior chamber of
the eye and innervation by sympathetic axons from the
adjacent iris or from cotransplanted sympathetic ganglia
and cross-innervation studies in adult cats, provide further
support for this model (Stevens and Landis, 1990; Cowen et
al., 1996; Koltzenburg et al., 1996).
Until recently, cholinergic function in the sweat gland
innervation has been assessed by assaying either ChAT
activity in tissue homogenates of sweat glands or secretory
responsiveness of the glands to muscarinic agonists. ChAT
is the synthetic enzyme for acetylcholine and secretory
responsiveness requires functional cholinergic innervation.
Neither assay reveals cholinergic function in the early
sweat gland innervation (Leblanc and Landis, 1986; Stevens
and Landis, 1987). Furthermore, assays of ChAT activity in
the transplanted tissues provided evidence that the appear-
ance of ChAT requires interactions with sweat glands
(Schotzinger and Landis, 1988, 1990). With the cloning of
the vesicular acetylcholine transporter (VAChT) and pro-
duction of anti-VAChT antisera (Roghani et al., 1994;
Gilmor et al., 1996; Weihe et al., 1996), it is possible to
examine the development of cholinergic function in the
sweat gland innervation with higher sensitivity and greater
spatial resolution. The coding sequence for VAChT, which
transports acetylcholine into synaptic vesicles, resides
within the first intron of the ChAT gene (Bejanin et al.,
1994; Erickson et al., 1994) and expression of the two genes
is coordinately regulated in sympathetic neurons (Berrard
et al., 1995; Misawa et al., 1995). Immunoreactivity for
VAChT (Weihe et al., 1996), like that of ChAT (Leblanc and
Landis, 1986), is present in the mature sweat gland inner-
vation. In a recent study, Schafer and colleagues (1997)
described the presence of VAChT immunoreactivity in the
sweat glands of front footpads at P4, the developmental
stage at which sympathetic axons had been previously
reported to contact sweat glands in hind footpads (Landis
and Keefe, 1983). This observation, coupled with the ex-
pression of ChAT and VAChT mRNA in embryonic sym-
pathetic ganglia, led Schafer et al. to conclude that cholin-
ergic differentiation occurs in sympathetic neurons before
contact with the sweat gland target tissue and independent
of sweat gland interactions (Schafer et al., 1997). Similarly,
Ernsberger and colleagues concluded that the acquisition of
cholinergic properties by avian sympathetic neurons does
not require target instruction since ChAT mRNA appears
in embryonic chick ganglia before target contact has been
described (Ernsberger et al., 1997).
To reconcile these apparently contradictory observations,
we have determined when VAChT immunoreactivity first
appears in the developing sweat gland innervation and
corresponding neuron cell bodies and compared the acqui-
sition of VAChT to the arrival of sympathetic axons in the
target tissue. We find that in both front and hind footpads,
VAChT immunoreactivity appears in sympathetic sweat
gland-associated fibers several days after contact has been
established with glands. Furthermore, the cell bodies of
neurons that innervate sweat glands and are labeled by
injection of a retrograde tracer into footpads do not contain
VAChT immunoreactivity before it is detected in footpad
axons. Finally, VAChT is not evident in gland-targeted
sympathetic axons in footpads of tabby mutant mice,
which lack sweat glands (Gruneberg, 1971). These results
confirm the role of sweat glands in inducing cholinergic
properties in noradrenergic sweat gland innervation.
METHODS
Animals
Sprague–Dawley rats were obtained from Taconic (Germantown,
NY) and Harlan (Indianapolis, IN). Footpads from at least five
animals were examined at each age (n 5 30 front footpads, 25 hind
footpads, each age). Some rat pups were injected ip with 50 mg/kg
reserpine phosphate in 50% ethanol. Controls received vehicle.
Twenty-four hours later, the animals were killed and footpads
processed for catecholamine histofluorescence with the addition of
0.001% Malachite Green to the glyoxylic acid solution as a
counterstain (de La Torre, 1980). Footpads from three treated and
three control animals were examined at P2, P5, and P9. Tabby
(B6CBACa-Aw-J/A-Ta/O) mutant mice were obtained from Jackson
Laboratory (Bar Harbor, ME). Footpads from nine tabby and nine
control mouse pups were examined. In addition, we examined the
stellate and lumbar ganglia from four adult tabby mice. Tabby
mutant and ‘‘high-expresser’’ K14-NGF transgenic mice (Albers et
al., 1994) were crossed to generate tabby/K14-NGF double mu-
tants. Footpads of five animals were examined. Animals were
killed with ether gas in accordance with NIH guidelines. The two
large interdigital footpads of the hind feet (rats and mice) and three
palmar footpads of the front feet (rats) were analyzed.
Immunohistochemistry
Tissue from rats perfused with 2 or 4% paraformaldehyde for 10
min was further fixed by immersion in the same fixative for 6 h at
room temperature. Tissues were rinsed in phosphate-buffered saline
(PBS) and equilibrated in 30% sucrose in 0.1 M phosphate buffer at
4°C. Ten-micron cryostat sections mounted on gelatin-coated slides
were rinsed in PBS, incubated in dilution buffer containing 2% bovine
serum albumin, 0.3% Triton X-100, and 0.1% sodium azide in PBS for
1 h, and then incubated with primary antisera in dilution buffer
overnight at room temperature. Sections were rinsed and incubated
with species-specific secondary antisera in dilution buffer for 2 h,
rinsed again, and coverslipped with 50% glycerol in PBS. For VAChT
staining, the sections were preincubated in dilution buffer for 8 h at
4°C and incubated for 72 h at 4°C in the primary antiserum. The
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VAChT antiserum was generated in rabbit against an 11-amino-acid
peptide corresponding to the C-terminal region of rat VAChT
(Roghani et al., 1998). Affinity-purified antiserum was diluted
1:40,000. The rabbit anti-rat TH antiserum (1:300) was from Pel-Freez
(Rogers, AR) and sheep anti-mammal TH (1:200) was from Chemicon
(Temecula, CA). Secondary antibodies were conjugated to Oregon
Green 512 (Molecular Probes, Eugene, OR), rhodamine and fluores-
cein isothiocyanate, or biotin–avidin–Cy3 or –Texas Red (Jackson
Immunoresearch, West Grove, PA). Sections were double labeled
using primary antisera raised in different species and species-specific
secondary antisera from Jackson. During our initial studies, we
explored several different techniques for visualizing VAChT immu-
noreactivity, including a peroxidase-conjugated secondary antiserum
like that used by Schafer et al. (1997) and peroxidase–anti-peroxidase,
and found that the biotin–avidin–Cy-3 or –Texas Red was superior.
Retrograde Labeling
Rat pups were anesthetized at P0, P1, P3, P4, and P12 and
crystals of Fast Blue (Sigma, St. Louis, MO) were inserted through
small incisions in the front and/or hind paw footpads. The inci-
sions were made in the center of the pad, perpendicular to the
surface, and extended almost to the base of the pad so that the
entire core of the footpad contained Fast Blue. Forty-eight hours
later, pups were killed and perfused with 2% paraformaldehyde. In
some experiments, animals that received footpad injections in the
early postnatal period were examined at 14 days. Stellate and
lumbar sympathetic ganglia were dissected, postfixed for 6 h, and
equilibrated in 30% sucrose. Five-micron cryostat sections were
processed for immunohistochemistry as described above.
RESULTS
VAChT Expression in the Developing Sweat Gland
Innervation
We examined catecholamine histofluorescence and
TH-IR to determine when sympathetic axons arrive in the
footpads and contact sweat gland primordia. Catechol-
amine histofluorescent axons were first detected in front
footpads at embryonic day 22 (E22). At P1, sparse, un-
branched fibers were evident in the central region of the
presumptive sweat gland field. Coincident with the elabo-
ration of the glands, the sympathetic axonal arbors ex-
panded so that an extensive catecholaminergic (Fig. 1) and
TH-IR plexus was well established by P3. Development of
sympathetic innervation of sweat glands in hind footpads
lagged approximately 1–2 days behind that of the front
footpads. At P2, individual, mostly unbranched cat-
echolaminergic fibers were detected in the core of hind
footpads and catecholaminergic axons were associated with
the growing glands by P4 (Fig. 1).
While a catecholaminergic and TH-IR plexus was well
established at P2 in front footpads and P4 in hind footpads,
we did not detect VAChT-IR in fibers innervating the
developing sweat glands until P4 in front footpads and P5–6
in hind footpads (Fig. 2). In typical sections of sweat glands
in the front footpads at P4 and of sweat glands in the hind
footpads at P5–6, VAChT immunofluorescence was faint
and associated with only a fraction of the glands that were
invested with TH-IR fibers (Fig. 2). At P5, VAChT-IR was
more intense in the innervation of sweat glands in front
footpads than that in the relatively small number of immu-
noreactive fibers seen in hind footpads. VAChT-IR was
more reliably detected in hind pads at P6. During the next
2 weeks, VAChT immunofluorescence increased in inten-
sity and became uniformly expressed in the sweat gland
innervation. By P17 in sweat glands of both front and hind
footpads, VAChT-IR had attained the staining intensity
observed in adult rats (Fig. 2).
Development of VAChT Immunoreactivity in
Sweat Gland Neuron Cell Bodies
VAChT and ChAT mRNA and VAChT-IR are present in
embryonic sympathetic neurons before their axons are
believed to have reached their target tissues (Ernsberger et
al., 1997; Schafer et al., 1997). To determine whether
VAChT-IR is present in the cell bodies of neurons that
innervate sweat glands before it appears in their axons, we
identified neurons projecting to sweat glands with the
retrograde tracer Fast Blue. Axon terminals in hind footpads
were exposed to Fast Blue and the retrogradely labeled
neurons in the lower lumbar ganglia were probed for
VAChT and TH immunoreactivities. When footpads were
injected at P2 and the lower lumbar ganglia examined at P4,
before the sweat gland innervation has developed VAChT-
IR, retrogradely labeled neurons (36 neurons; five animals)
lacked detectable VAChT-IR. They did, however, contain
TH-IR (Fig. 3). While no Fast Blue-labeled neurons ex-
pressed VAChT-IR, some neurons that lacked the retro-
FIG. 1. Catecholamine histofluorescent fibers (arrows) innervated
developing sweat glands (asterisks) at P2 in front footpads (a); and
P4 in hind footpads (b). Scale bar, 20 mm.
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grade label contained VAChT. Some expressed both
VAChT and TH immunoreactivities (4 of 28 neurons),
while the majority contained VAChT but not TH-IR (24 of
28 neurons) (Fig. 3). When littermates which received
footpad injections at P12 were examined at P14, many Fast
Blue-labeled neurons were brightly VAChT and TH-IR (24
neurons; five animals) (Fig. 3). In addition, some retro-
gradely labeled neurons lacked VAChT but contained TH
(19 neurons). As in younger animals, neurons that lacked
Fast Blue and were either VAChT immunoreactive (25 of 30
neurons) or both VAChT-IR and TH-IR (5 of 30) were also
present at P14. Analysis of retrogradely labeled neurons in
stellate ganglia, which innervate sweat glands in front
footpads, yielded comparable results (data not shown). Stel-
late neurons labeled after injection of Fast Blue in front
footpads at P1 lacked VAChT-IR at P3 and were very
weakly VAChT-IR at P5 and brightly immunoreactive by
P14. Similar results were obtained when stellate and lum-
bar ganglia were examined at P14 after Fast Blue application
in the early postnatal period. Since the fluorescent retro-
grade label was less intense in those cells, neuron counts
were obtained only from P14 animals labeled 48 h earlier.
FIG. 2. TH-IR fibers (arrows) innervated sweat glands (asterisks) at P3 in (a) front and (b) hind footpads lacked VAChT-IR (c and d). VAChT was
apparent in gland innervation in front footpads (arrows) at P5 (e). Although very weak immunoreactivity was detected in rare fibers (arrow) in hind
footpads from the same rat (f), VAChT was not consistently detected until P6 in most hind footpads and then only a small fraction of sympathetic
fibers were detected. By P17, VAChT-IR (arrows) was robust in the gland innervation of both front (g) and hind footpads (h). Scale bar, 20 mm.
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VAChT Does Not Appear in the Absence
of Sweat Glands
In tabby mutant mice which lack sweat glands
(Gruneberg, 1971), catecholaminergic sympathetic axons
transiently innervate the presumptive sweat gland field
(Guidry and Landis 1995). If the acquisition of cholinergic
properties in sweat gland neurons does not require inter-
actions with their target tissue, then VAChT-IR should
be present in the gland-targeted sympathetic axons. We
did not, however, observe VAChT-IR in hind footpads of
tabby mutant mice at P9 or P10, ages when it is readily
detectable in gland-associated fibers of wild-type mice
(Fig. 4).
To determine whether cholinergic sympathetic neurons
which might innervate targets other than the sweat glands
were present in tabby mutant mice, we examined neurons
in the stellate and lumbar ganglia of adult animals for
VAChT and tyrosine hydroxylase immunoreactivities. We
found a number of VAChT-IR neurons in both ganglia. As
in ganglia from a P14 rat, some of these neurons contained
tyrosine hydroxylase immunoreactivity while others
lacked it (Fig. 5). These observations indicate that cholin-
ergic properties can be expressed by sympathetic neurons in
tabby mice.
The presumptive sweat gland innervation in tabby
mutant mice disappears from the central region where
glands would have formed by P15, presumably due to the
absence of trophic support normally provided by their
target sweat glands. To determine whether cholinergic
properties appear in the absence of sweat glands when
gland-targeted sympathetic axons are maintained with an
alternative source of trophic support, tabby mutant mice
were crossed with transgenic mice (K14-NGF) in which
nerve growth factor (NGF), under the control of a keratin
promoter, is overexpressed in the epidermis (Albers et al.,
1994). NGF increases transmitter synthesis in sympa-
thetic neurons but does not determine which transmitter
is expressed (Chun and Patterson, 1977a,b). Tabby/K14-
NGF mouse footpads, like those of tabby mice, lack
sweat glands. In the double-mutant mice, thick bundles
of TH-IR fibers coursed through the glandless pad core to
form an extensive plexus beneath the dermal/epidermal
border. When adjacent sections were stained for VAChT
or sections were double labeled for TH and VAChT, no
VAChT immunoreactivity was evident in this plexus
(Fig. 5) in 19 of 20 interdigital footpads examined (two
pads each from both hind feet from five mice). In a single
region of one pad, a small cluster of VAChT-IR fibers was
present. In contrast, VAChT was readily detected in
neuromuscular junctions in striated muscle (Fig. 6).
FIG. 3. At P4, neurons (arrow) in the lumbar ganglia that had been retrogradely labeled by injection of Fast Blue in hind footpads (a) lacked
VAChT-IR (b) but contained TH (c). In addition, the ganglia contained other neurons that were not retrogradely labeled (d), were VAChT-IR
(e), and usually lacked TH (f). At P14, retrogradely labeled neurons (g) contained both VAChT (h) and TH (I). As in younger animals, other
VAChT-IR (k), TH-negative (l) neurons that lacked the retrograde label (j) were present. Scale bar, 20 mm.
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Vesicular Monoamine Transporter(s) Are Present
in Sweat Gland Innervation
In noradrenergic neurons, catecholamines are transported
from the cytoplasm into synaptic vesicles by the neuronal
vesicular monoamine transporter (VMAT2) where they are
protected from breakdown by monoamine oxidases and
stored for release (Liu and Edwards, 1997). While Schafer
and colleagues observed VAChT-IR in the developing sweat
gland innervation, they did not detect immunoreactivity for
VMAT2 (Schafer et al., 1997). They concluded from the
absence of staining that while the developing sweat gland
innervation expresses a number of noradrenergic properties,
the innervation lacks VMAT2 and vesicular stores of cat-
echolamines and is therefore not functionally noradrener-
gic. The developing sweat gland innervation, however, does
contain catecholamine histofluorescence and small granu-
lar vesicles after permanganate fixation, suggesting that
catecholamines are indeed sequestered in vesicles (Landis
and Keefe, 1983). To verify that the catecholamine fluores-
cence observed after formaldehyde or glyoxylic acid treat-
ment reflects vesicular stores, we used a pharmacological,
rather than an immunocytochemical, assay for vesicular
transporter(s). Rat pups were injected with reserpine, an
irreversible inhibitor of the vesicular monoamine trans-
porter, or vehicle at P2, P5, and P9. In control pups injected
with vehicle, catecholamine histofluorescence was de-
tected in the sweat gland innervation in both front and hind
footpads 24 h later. In contrast, no catecholamine histofluo-
rescence could be detected in the footpad innervation of the
reserpine-treated littermates (Fig. 7). The loss of catechol-
amine histofluorescence after reserpine treatment demon-
strates that in the developing sweat gland innervation,
catecholamines are stored in vesicles that contain a
reserpine-sensitive monoamine transporter.
DISCUSSION
Our findings indicate that VAChT-IR is not detectable in
sympathetic axons when they first arrive in footpads and
contact the developing sweat glands. Like Schafer et al.
FIG. 4. Control mouse sweat gland innervation at P10 contained
both TH (a) and VAChT-IR (b). In contrast, TH-IR fibers (arrows)
innervating tabby footpads at P10 (c) lacked VAChT immunoreac-
tivity (d). Scale bar, 20 mm.
FIG. 5. Lumbar sympathetic ganglia of adult tabby mutant mice contained neurons that coexpressed (a) VAChT and (b) TH (arrows) and
(c) other neurons that expressed VAChT but lacked TH (arrow). VAChT-IR fibers innervating TH-IR neurons in (c) are marked with
arrowheads. Scale bar, 50 mm.
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(1997), we first observed VAChT immunoreactivity in the
innervation of sweat glands in front footpads at P4. At this
age, VAChT-IR was faint and appeared in only a fraction of
the sympathetic fibers identified by their robust expression
of TH-IR. While Schafer and colleagues assumed that sym-
pathetic fibers contact sweat glands in the front footpads at
P4, the same time that such fibers had been reported to
contact sweat glands in hind footpads (Landis and Keefe,
1983), we found a sympathetic plexus already well estab-
lished in front footpads at this age. In fact, sympathetic
fibers are uniformly present in front footpads at birth.
TH-IR fibers arrived in the hind footpads at P1, earlier than
previously reported (Landis and Keefe, 1983; Landis et al.,
1988), but VAChT was not consistently detected in axons
until P6. The delayed appearance of VAChT-IR confirms
that cholinergic function, previously assessed with ChAT
assays and secretory responsiveness (Leblanc and Landis,
1986; Stevens and Landis, 1987), is not detectable in the
initial sweat gland innervation. While cholinergic function
is absent from the early sweat gland innervation, cat-
echolaminergic properties are present (Landis and Keefe,
1983; Landis et al., 1988). Further, the developing sweat
gland innervation is eliminated by treatment with the
noradrenergic neurotoxin 6-hydroxydopamine (Yodlowski
et al., 1984). The catecholamines appear to play a role in the
target-directed change in transmitter phenotype. In culture,
catecholamines trigger production of cholinergic differen-
tiation factor by developing sweat glands (Habecker and
Landis, 1994; Habecker et al., 1995) and analysis of
catecholamine-deficient mice suggests that catecholamines
facilitate the induction of cholinergic function (Tsahai
Tafari et al., 1997). Schafer and colleagues did not detect
VMAT2-IR in the developing sweat gland innervation
(Schafer et al., 1997). However, we found that reserpine
treatment, a pharmacological assay for vesicular catechol-
amine transport, abolished catecholamine histofluores-
cence, consistent with the presence of small granular
vesicles after permanganate fixation (Landis and Keefe,
1983). Thus, the sympathetic fibers associated with sweat
glands contain catecholamines which are stored in vesicles
and therefore releasable. The failure to detect VMAT2-IR
could reflect difficulty in detection of relatively low levels
of transporter in the sweat gland terminals or possibly the
presence of a different monoamine transporter or isoform
variant. Consistent with these possibilities, Habecker, us-
ing an antiserum generated against the same peptide se-
quence of VMAT2 as Schafer et al. (1997), occasionally
observed VMAT2 immunoreactivity in the developing or
adult sweat gland innervation (B. A. Habecker, personal
communication).
While VAChT was not detected in sympathetic fibers
when they arrived in the footpads to contact the developing
glands, it was possible that VAChT-IR was present in
neuron cell bodies but not efficiently transported to axon
terminals. To address this issue, we used a retrograde label
to identify neurons projecting to footpads. We found that
the retrogradely labeled neurons, like axon terminals in the
glands, initially expressed TH-IR but lacked VAChT.
VAChT-IR became detectable in retrogradely labeled cell
bodies coincident with expression in sweat gland axons and
FIG. 6. (a) Large, TH-IR fascicles extend from the base of the
tabby/K14-NGF footpad through the core to the pad perimeter
where the axons form a dense plexus at the dermal/epidermal
border (arrows). (b) VAChT-IR is absent from the fascicles and
plexus viewed in the adjacent section, although VAChT-IR is
evident in a motor end plate in muscle subjacent to the pad (arrow).
e, epidermis. Scale bar, 40 mm.
FIG. 7. Catecholamine histofluorescent axons are associated with
the developing secretory tubules in front footpads at P3 (a) and hind
footpads at P6 (c). At each age, littermates pups injected with
reserpine phosphate lacked catecholamine histofluorescence (b, d).
Scale bar, 20 mm.
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by P14 many retrogradely labeled neurons contained both
TH and VAChT-IR. Not all neurons retrogradely labeled
from footpad injections at P12 and examined at P14 con-
tained VAChT-IR. In the older animals, labeled neurons
which contained only TH-IR presumably provide cat-
echolaminergic innervation to footpad blood vessels (Landis
and Keefe, 1983; Landis et al., 1988). Similarly, some
neurons retrogradely labeled before P4 are likely to inner-
vate blood vessels.
The finding that VAChT appears in sweat gland axons
and cell bodies after contact with sweat glands is consistent
with the view that interactions with the sweat gland target
induce VAChT expression. The most compelling test of
this hypothesis requires analysis of the presumptive sweat
gland innervation in the absence of target tissue. The tabby
mutation provides genetic ablation of sweat glands without
disruption of other footpad tissue compartments (Grune-
berg, 1971; Rao et al., 1994; Guidry and Landis, 1995).
Sympathetic axons pathfind accurately to the region of
tabby footpads where glands should form and remain for 7
to 10 days despite the absence of their normal target
(Guidry and Landis, 1995). If VAChT expression in sweat
gland neurons occurred independent of target interactions,
then VAChT-IR should be present in the gland-targeted
sympathetic axons in tabby footpads. No VAChT-IR, how-
ever, was detected during development in sympathetic
fibers in tabby footpads. This was the case even in adult
double-mutant tabby/K14-NGF mice in which overexpres-
sion of NGF in the epidermis rescued gland-targeted sym-
pathetic axons. These observations significantly extend
findings from previous transplantation and culture studies.
Sweat gland primordia transplanted in place of hairy skin
reduce the expression of catecholaminergic properties and
induce ChAT in noradrenergic piloerrector neurons
(Schotzinger and Landis, 1988; Schotzinger et al., 1994).
Similarly, coculture of sympathetic neurons with sweat
glands or treatment of sympathetic neurons with sweat
gland extracts induces ChAT activity (Rao et al., 1992;
Rohrer, 1992; Habecker and Landis, 1994; Habecker et al.,
1995). Together, these findings indicate that sweat glands
can suppress noradrenergic and induce cholinergic func-
tion. When sweat gland primordia are replaced with parotid
glands, which receive noradrenergic sympathetic innerva-
tion, sympathetic axons innervating the transplanted
glands retain noradrenergic properties and fail to acquire
ChAT (Schotzinger and Landis, 1990). The results of this
transplant study are consistent with target instruction, but
it was possible that parotid gland promoted noradrenergic
differentiation at the expense of cholinergic differentiation.
The present studies with tabby and tabby/K14-NGF mice
resolve this issue by demonstrating that in the absence of
sweat glands, gland-targeted sympathetic axons do not
express VAChT.
While the present findings confirm previous studies sug-
gesting that the appearance of cholinergic properties in
sweat gland neurons requires interactions with their target
tissue, it is unclear whether a target-derived instructive
signal is required for the induction of cholinergic properties
in other populations of cholinergic sympathetic neurons.
We observed VAChT-IR neurons that lacked retrograde
label in stellate and lumbar ganglia at P3 and P4 and
therefore presumably innervate cholinergic sympathetic
targets other than sweat glands. The presence of VAChT-IR
neurons in the sympathetic ganglia of adult tabby mutant
mice, which lack sweat glands, is consistent with this
interpretation. At least some of these neurons are likely to
innervate periosteum, the connective tissue covering of
bone. Striking similarities exist between the development
of transmitter properties in periosteal and sweat gland
innervation (Francis et al., 1997; Asmus and Landis, 1998).
As in the case of sweat gland innervation, the initial
innervation of the periosteal covering of the sternum is
catecholaminergic, neonatal treatment with the noradren-
ergic neurotoxin, 6-hydroxydopamine, eliminates sympa-
thetic periosteal innervation, and periosteum transplanted
beneath hairy skin reduces catecholaminergic properties
and induces VAChT-IR in piloerrector neurons. Many
TH-IR axons that lack VAChT-IR upon arrival in the
sternum presumably acquire it as a consequence of inter-
actions with the periosteum. In contrast to the early sweat
gland innervation which contains TH-IR and uniformly
lacks VAChT-IR, at E18 some of the axons that have
reached the sternum contain not only TH-IR but also
VAChT. The presence of VAChT-IR in these axons is likely
to result from the fact that the axons of thoracic neurons
grow along the rib periosteum to reach the sternum.
While periosteum is likely to be the target of some
VAChT-IR neurons present at P3 and P4, others may
innervate cholinergic sympathetic targets that have not yet
been identified in rodents; for example, cholinergic sympa-
thetic vasodilatation is well established in other mammals
(Uvnas, 1966). The neurons that innervate such putative
targets could possess a developmental history different
from that of sweat gland and periosteal neurons; they could
lack the early expression of catecholaminergic properties
and acquire cholinergic properties independent of target
interactions. Until all the targets of cholinergic sympa-
thetic neurons have been identified and the time course of
innervation and VAChT appearance compared, it is not
possible to conclude whether or not the cholinergic proper-
ties expressed by these neurons require target interactions
as we have demonstrated for the neurons that innervate
sweat glands.
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